← All trials
NCT06541639
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 1, 2024
- Primary completion
- Mar 31, 2028
- Completion date
- Jun 30, 2028
- First posted
- Aug 7, 2024
- Last posted
- Aug 7, 2024
- Enrollment
- 78
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Peking UniversityLead sponsor
- Peking UniversityOfficial
- Fudan UniversityCollaborator
- Peking UniversitySponsor investigator
- Everest MedicinesCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.